Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2024-04-26 Earnings Release
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE THREE MONTHS ENDED 31 MARCH 2024
Earnings Release Classification · 95% confidence The document is an announcement of unaudited financial results for the three months ended 31 March 2024 for CR Double-Crane, a subsidiary of China Resources Pharmaceutical Group Limited. It includes key financial figures such as revenue, net profit, cash flow, total assets, liabilities, and owner's equity. The document explicitly states that the financials are unaudited and prepared according to PRC GAAP, and it advises caution to shareholders and investors. The document is relatively short (3496 characters) and serves as a summary announcement rather than a full detailed quarterly report. It also directs readers to the full quarterly report published on the Shanghai Stock Exchange website. Given these factors, this document is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only, rather than a full Interim/Quarterly Report (IR) which would contain comprehensive financial statements and analysis. Q1 2024
2024-04-26 English
2023 Sustainability Report
Environmental & Social Information Classification · 100% confidence The document is titled 'Sustainability Report China Resources Pharmaceutical Group Limited' and contains extensive content related to environmental, social, and governance (ESG) factors, including an independent assurance opinion statement by the British Standards Institution. The report references compliance with HKEX ESG Reporting Guide and GRI standards, and discusses sustainability management, environmental impact, social responsibility, and governance practices. There is no indication that this is a financial report, earnings release, or regulatory filing related to financial performance. Instead, it is a detailed ESG report with assurance, fitting the definition of an Environmental & Social Information report. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification letter. Therefore, the appropriate classification is Environmental & Social Information (SR).
2024-04-25 English
Notification of publication of corporate communications on the Company's website
Report Publication Announcement Classification · 100% confidence The document is a notification letter dated 26 April 2024 from China Resources Pharmaceutical Group Limited informing non-registered holders about the publication of corporate communications on the company's website. It specifically mentions that the Annual Report 2023 and a circular dated 26 April 2024 are now available online. The letter also provides instructions for requesting printed copies of these documents. The text does not contain the actual Annual Report or the circular but rather announces their availability and provides access information. The document length is 6433 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is a report publication announcement, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2024-04-25 English
Letter to new shareholders - election of means of receipt of corporate communications
Regulatory Filings Classification · 95% confidence The document is a letter dated 26 April 2024 from China Resources Pharmaceutical Group Limited to shareholders regarding the election of means of receipt of corporate communications. It includes an instruction slip for shareholders to choose whether to receive future corporate communications electronically or in printed form. The letter references the Sustainability Report 2023 being published electronically and offers shareholders the option to request printed copies. It also mentions the Annual Report 2023, a circular dated 26 April 2024, and a proxy form for the upcoming annual general meeting on 30 May 2024, but does not contain the actual reports or financial data itself. The document is primarily an announcement and request for shareholder action regarding communication preferences, not the report or financial statements themselves. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and shareholder communication that does not contain substantive financial data or the report itself.
2024-04-25 English
Letter to those shareholders who have elected to receive the corporate communications through the Company's website
Report Publication Announcement Classification · 95% confidence The document is a letter dated 26 April 2024 from China Resources Pharmaceutical Group Limited to shareholders who have elected to receive corporate communications electronically. It notifies shareholders that the Annual Report 2023, a circular dated 26 April 2024 relating to general mandates and re-election of directors, and the proxy form for the AGM on 30 May 2024 are available on the company's website. The letter also includes an instruction slip for shareholders to request printed copies or change their means of receipt for future communications. The document does not contain the actual Annual Report or financial data but is an announcement about the availability of these reports and related meeting materials. It also mentions the Sustainability Report 2023 is published electronically only. Given the document's nature as a notification of report availability and instructions for shareholders, it fits the category of Report Publication Announcement (RPA) rather than the Annual Report (10-K) or other report types.
2024-04-25 English
Letter to those shareholders who have elected to receive the printed form of corporate communications
Report Publication Announcement Classification · 95% confidence The document is a letter dated 26 April 2024 addressed to shareholders of China Resources Pharmaceutical Group Limited. It encloses the Annual Report 2023, a Circular dated 26 April 2024, and a Proxy form for the upcoming Annual General Meeting on 30 May 2024. The letter also provides instructions for shareholders to elect their preferred means of receiving corporate communications, including printed or electronic forms. The document does not contain the actual Annual Report or financial statements but rather serves as a communication to shareholders about the availability and distribution of the Annual Report and related meeting materials. It also mentions the Sustainability Report 2023 is published electronically and can be requested in print. Given the document's nature as a cover letter and instruction slip for receiving the Annual Report and proxy materials, it fits the definition of a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself. The document length (6355 characters) and content support this classification as it is not the full report but an announcement and distribution instruction.
2024-04-25 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.